1. Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation
    Ioannis Voutsadakis, 2016, JCM CrossRef
  2. Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment
    Benjamin Owusu et al, 2017, Cancers CrossRef
  3. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
    Bowen Du et al, 2016, Molecules CrossRef
  4. Primary breast cancer cell culture yields intra-tumor heterogeneous subpopulations expressing exclusive patterns of receptor tyrosine kinases.
    José Esparza-López et al, 2016, BMC Cancer CrossRef
  5. Polyphenolic Nutrients in Cancer Chemoprevention and Metastasis: Role of the Epithelial-to-Mesenchymal (EMT) Pathway.
    Haneen Amawi et al, 2017, Nutrients CrossRef
  6. miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer
    Shihua Chu et al, 2017 CrossRef
  7. Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9
    Jian-Ping Gong et al, 2016 CrossRef
  8. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
    Jing Luo et al, 2018, J Exp Clin Cancer Res CrossRef
  9. Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway
    Jie Li et al, 2018, Front. Pharmacol. CrossRef
  10. The Role of Hepatocyte Growth Factor (HGF) in Insulin Resistance and Diabetes
    Alexandre G. Oliveira et al, 2018, Front. Endocrinol. CrossRef
  11. RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma.
    Zhengshuai Song et al, 2018, Exp Cell Res CrossRef
  12. GeneExpressScore Signature: a robust prognostic and predictive classifier in gastric cancer
    Xiaoqiang Zhu et al, 2018, Mol Oncol CrossRef
  13. Epithelial-mesenchymal transition as a mechanism of resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma
    Hee Sang Hwang et al, 2019, Lab Invest CrossRef
  14. Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1/β-catenin signaling pathway in breast cancer
    Xiaoxia Jin et al, 2019, Cancer Med CrossRef
  15. The basics of epithelial-mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective.
    Vishal Das et al, 2019, J Cell Physiol CrossRef
  16. Modulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma In Vitro and In Vivo
    Sonja Stojković Burić et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  17. Glucocorticoid receptor–IRS-1 axis controls EMT and the metastasis of breast cancers
    Weiwei Shi et al, 2019 CrossRef
  18. Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells.
    Yaxun Li et al, 2019, Chem Biol Interact CrossRef
  19. Cause-and-Effect Relationship Between FGFR1 Expression and Epithelial-Mesenchymal Transition in EGFR-Mutated Non-Small Cell Lung Cancer Cells
    Johan Vad-Nielsen et al, 2019, Lung Cancer CrossRef
  20. 3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway
    Junli Chen et al, 2016, Sci Rep CrossRef
  21. The mechanism of anticancer action and potential clinical use of kaempferol in the treatment of breast cancer
    Xueni Wang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  22. Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via β-catenin signaling
    Jie Li et al, 2019, Life Sciences CrossRef
  23. Piperine: role in prevention and progression of cancer
    Mariia Zadorozhna et al, 2019, Mol Biol Rep CrossRef
  24. Therapies to Overcome Multidrug-Resistant Receptors
    Noura Al-Zeheimi et al, 2019 CrossRef
  25. Circular RNAs in drug resistant tumors
    Xin Hua et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  26. Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review
    Heewa Shakib et al, 2019, Endocrine CrossRef
  27. Inhibition of Epithelial-to-Mesenchymal Transition (EMT) by Hyperthermia
    Satoshi Kokura, 2016 CrossRef
  28. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1
    Bei Wang et al, 2016, PLoS ONE CrossRef
  29. The Evaluation of Glioblastoma Cell Dissociation and Its Influence on Its Behavior
    Veronika Skarkova et al, 2019, IJMS CrossRef
  30. Identifying drug resistant cancer cells using microbubble well arrays
    Qihui Pu et al, 2017, Biomed Microdevices CrossRef
  31. The “good-cop bad-cop” TGF-beta role in breast cancer modulated by non-coding RNAs
    Diana Gulei et al, 2017, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
  32. Induced Tamoxifen Resistance is Mediated by Increased Methylation of E-Cadherin in Estrogen Receptor-Expressing Breast Cancer Cells.
    Qi Wang et al, 2019, Sci Rep CrossRef
  33. The LQB-223 Compound Modulates Antiapoptotic Proteins and Impairs Breast Cancer Cell Growth and Migration
    Lauana Greicy Tonon Lemos et al, 2019, IJMS CrossRef
  34. Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence.
    Shian-Ren Lin et al, 2020, Br J Pharmacol CrossRef
  35. miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4.
    Feiya Du et al, 2019, Cell Death Dis CrossRef
  36. Punicalagin inhibits the viability, migration, invasion, and EMT by regulating GOLPH3 in breast cancer cells
    Lei Pan et al, 2020, Journal of Receptors and Signal Transduction CrossRef
  37. Immunofluorescence Analysis of the Vimentin Expression in Epithelial Cells
    T. A. Bogush et al, 2019, Moscow Univ. Chem. Bull. CrossRef
  38. Prognostic value of epithelial‐mesenchymal transition‐inducing transcription factors in head and neck squamous cell carcinoma: A meta‐analysis
    Yuehan Wan et al, 2020, Head & Neck CrossRef
  39. A non-proliferative role of pyrimidine metabolism in cancer
    Aarif Siddiqui et al, 2020, Molecular Metabolism CrossRef

  40. Leucine Zipper-EF-Hand Containing Transmembrane Protein 1 Is a Potential Prognostic Biomarker and Promotes Cell Progression in Prostate Cancer


    Lihua Piao et al, 2020, CMAR CrossRef
  41. DNASE1L2, as a Carcinogenic Marker, Affects the Phenotype of Breast Cancer Cells Via Regulating Epithelial–Mesenchymal Transition Process
    Chang-Rui Liu et al, 2020, Cancer Biotherapy and Radiopharmaceuticals CrossRef
  42. Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1
    Xiaoping Pan et al, 2020, Front. Oncol. CrossRef
  43. Long Non-Coding RNA HOTAIR in Breast Cancer Therapy
    Monica Cantile et al, 2020, Cancers CrossRef
  44. Sphk1 Participates in Malignant Progression of Breast Cancer by Regulating Epithelial-mesenchymal Transition and Stem Cell Characteristics
    Zhijie Chen et al, 2020, Tissue and Cell CrossRef
  45. Flaming the fight against cancer cells: the role of microRNA-93
    Milad Ashrafizadeh et al, 2020, Cancer Cell Int CrossRef
  46. Overexpression of Extradomain-B Fibronectin is Associated with Invasion of Breast Cancer Cells
    Amita Vaidya et al, 2020, Cells CrossRef
  47. Characterizing the Relapse Potential in Different Luminal Subtypes of Breast Cancers with Functional Proteomics
    Tung-Yi Lin et al, 2020, IJMS CrossRef
  48. MicroRNA-7 targets T-Box 2 to inhibit epithelial-mesenchymal transition and invasiveness in glioblastoma multiforme
    Chih-Ming Pan et al, 2020, Cancer Letters CrossRef
  49. The Effect of TIGAR Knockdown on Apoptotic and Epithelial‐Mesenchymal Markers Expression in Doxorubicin‐Resistant Non‐Small Cell Lung Cancer A549 Cell Lines
    Can Ali Agca et al, 2020, C&B CrossRef
  50. Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: a retrospective multicenter cohort study
    Hiroshi Imaoka et al, 2020, BMC Cancer CrossRef
  51. CACNA1B facilitates breast cancer cell growth and migration by regulating cyclin D1 and EMT: the implication of CACNA1B in breast cancer
    Yong-Mei Jin et al, 2020, Journal of Receptors and Signal Transduction CrossRef
  52. Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro–In Silico Model
    José Eduardo Vargas et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
  53. Verminoside from Pseudolysimachion rotundum var. subintegrum sensitizes cisplatin-resistant cancer cells and suppresses metastatic growth of human breast cancer
    Changhu Lee et al, 2020, Sci Rep CrossRef
  54. Three-Dimensional Breast Cancer Models Mimic Hallmarks of Size-Induced Tumor Progression
    Manjulata Singh et al, 2016, Cancer Res CrossRef
  55. Preclinical Activity of Ribociclib in Squamous Cell Carcinoma of the Head and Neck
    Gabrielle van Caloen et al, 2020, Mol Cancer Ther CrossRef
  56. The Metabolic Mechanisms of Breast Cancer Metastasis.
    Lingling Wang et al, 2020, Front Oncol CrossRef
  57. Prognostic Significance of CDH1, FN1 and VIM for Early Recurrence in Patients with Colorectal Liver Metastasis After Liver Resection
    Aleksandar Bogdanovic et al, 2021, CMAR CrossRef
  58. Impact of Selected Signaling Proteins on SNAIL 1 and SNAIL 2 Expression in Ovarian Cancer Cell Lines in Relation to Cells’ Cisplatin Resistance and EMT Markers Level
    Michal Kielbik et al, 2021, IJMS CrossRef
  59. Linc00665 Can Predict the Response to Cisplatin-Paclitaxel Neoadjuvant Chemotherapy for Breast Cancer Patients
    Huijuan Dai et al, 2021, Front. Oncol. CrossRef
  60. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer
    Yuhan Yang et al, 2020, Aging CrossRef
  61. Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis.
    Arpita Datta et al, 2021, Cancers (Basel) CrossRef
  62. SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancer
    Surya Kant Tripathi et al, 2021, Life Sciences CrossRef
  63. Multifunctional Liposomes Enable Active Targeting and Twinfilin 1 Silencing to Reverse Paclitaxel Resistance in Brain Metastatic Breast Cancer
    Jiawei Du et al, 2021, ACS Appl. Mater. Interfaces CrossRef
  64. Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer.
    Karam Soliman, 0 CrossRef
  65. Toward radiotheranostics in cancer stem cells: a promising initial step for tumour eradication
    Farzaneh Ghaderi et al, 2021, Clin Transl Imaging CrossRef
  66. Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma
    Xiu Hu et al, 2021, WJCC CrossRef
  67. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer
    Weiyu Dai et al, 2021, Front. Genet. CrossRef
  68. Cisplatin Plus Cetuximab Inhibits Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Migration and Proliferation but Does Not Enhance Apoptosis
    Hyeong Sim Choi et al, 2021, IJMS CrossRef
  69. Punicalagin in Cancer Prevention—Via Signaling Pathways Targeting
    Izabela Berdowska et al, 2021, Nutrients CrossRef
  70. 2-Hydroxypropyl-β-cyclodextrin Regulates the Epithelial to Mesenchymal Transition in Breast Cancer Cells by Modulating Cholesterol Homeostasis and Endoplasmic Reticulum Stress
    Yiyang Zhao et al, 2021, Metabolites CrossRef
  71. Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them
    Alisha Ramos et al, 2021, IJMS CrossRef
  72. Combined Treatment with Acalabrutinib and Rapamycin Inhibits Glioma Stem Cells and Promotes Vascular Normalization by Downregulating BTK/mTOR/VEGF Signaling
    Yu-Kai Su et al, 2021, Pharmaceuticals CrossRef
  73. Comprehensive Analysis to Identify the Epithelial–Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma
    Guozhi Wu et al, 2021, Front. Surg. CrossRef
  74. Practical approach to diagnosis of bland-looking spindle cell lesions of the breast
    G. Magro et al, 2019, Pathologica CrossRef
  75. The Herbal Formula JI017 Induces ER Stress via Nox4 in Breast Cancer Cells
    Tae Woo Kim et al, 2021, Antioxidants CrossRef
  76. Crosstalk between non-coding RNAs expression profile, drug resistance and immune response in breast cancer
    Seyed Ali Miraghel et al, 2021, Pharmacological Research CrossRef
  77. Curcumin as an Enhancer of Therapeutic Efficiency of Chemotherapy Drugs in Breast Cancer
    Reyhaneh Farghadani et al, 2022, IJMS CrossRef
  78. Prognostic value of STC1 in solid tumors: a meta-analysis
    Rongqi Li et al, 2022, Biomarkers in Medicine CrossRef
  79. Normal and Neoplastic Growth Suppression by the Extended Myc Network
    Edward V. Prochownik et al, 2022, Cells CrossRef
  80. Meme Kanserinde Tamoksifen Direncinde IL-6/STAT3 Yolağı Temelli EMT Mekanizmasının Rolünün Araştırılması
    Ahmet Yasir MEN et al, 2022 CrossRef
  81. Extracellular ATP and Macropinocytosis: Their Interactive and Mutually Supportive Roles in Cell Growth, Drug Resistance, and EMT in Cancer
    Maria Evers et al, 2022 CrossRef
  82. The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer
    Pingting Ye et al, 2022, Cancers CrossRef
  83. LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing LOXL2-induced epithelial-mesenchymal transition (EMT)
    Ting Peng et al, 2022, Cell Cycle CrossRef
  84. Evaluation of miRNA-21–5p and miRNA-10b-5p levels in serum-derived exosomes of breast cancer patients in different grades
    Ali Asadirad et al, 2022, Molecular and Cellular Probes CrossRef
  85. miRNAs Modulate the Dichotomy of Cisplatin Resistance or Sensitivity in Breast Cancer: An Update of Therapeutic Implications
    Asma Safi et al, 2021, ACAMC CrossRef
  86. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
    Hong Lin et al, 2022, Mol Cancer CrossRef
  87. Kaempferol attenuates viability of ex-vivo cultured post-NACT breast tumorexplants through downregulation of p53 induced stemness, inflammation and apoptosis evasion pathways
    Sourav Kumar Nandi et al, 2022, Pathology - Research and Practice CrossRef
  88. Cancer-associated Fibroblasts: Origin, Function, Imaging, and Therapeutic Targeting
    Rahul Rimal et al, 2022, Advanced Drug Delivery Reviews CrossRef
  89. β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features
    Soeun Park et al, 2022, Cancer Cell Int CrossRef
  90. Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cells
    Jeong-Yeon Mun et al, 2022, Cell Death Discov. CrossRef
  91. AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage
    Jin-peng Pei et al, 2023, Acta Pharmacol Sin CrossRef
  92. Prognostic value of nectin-4 in human cancers: A meta-analysis
    Rongqiang Liu et al, 2023, Front. Oncol. CrossRef
  93. SETDB1 induces lenalidomide resistance in multiple myeloma cells via epithelial‑mesenchymal transition and PI3K/AKT pathway activation
    Xiaoli Qian et al, 2023, Exp Ther Med CrossRef
  94. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Chemotherapy in Acute Myeloid Leukemia
    Shuang Qu et al, 2023, DDDT CrossRef
  95. Molecular Pathways in Breast Cancer Chemoresistance
    Subhayan Das et al, 2023 CrossRef
  96. Predictive miRNAs Patterns in Blood of Breast Cancer Patients Demonstrating Resistance Towards Neoadjuvant Chemotherapy
    Jingjing Fan et al, 2023, BCTT CrossRef
  97. DRMref: comprehensive reference map of drug resistance mechanisms in human cancer
    Xiaona Liu et al, 2023 CrossRef
  98. Role of cellular interaction and cell phenotype in azacytidine to doxorubicin sensitivity in breast cancer cell-derived clones
    Gul Nabi Khan et al, 2024, Human Gene CrossRef
  99. RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells
    Macheng Lu et al, 2023, Oncol Rep CrossRef
  100. Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response
    Nasim Ebrahimi et al, 2024, Cancer Metastasis Rev CrossRef
  101. Clinical impact of epithelial–mesenchymal transition for cancer therapy
    Nobendu Mukerjee et al, 2024, Clinical and Translational Dis CrossRef
  102. Cordia Dichotoma: A Comprehensive Review of its Phytoconstituents and Endophytic Fungal Metabolites and their Potential Anticancer Effects
    Saurav Madhavrao Patil et al, 2024, CTMC CrossRef
  103. Abemaciclib-induced epithelial-mesenchymal transition mediated by cyclin-dependent kinase 4/6 independent of cell cycle arrest pathway
    Tomoyo Yoshimori et al, 2024, The International Journal of Biochemistry & Cell Biology CrossRef
  104. Is Curcumin the Answer to Future Chemotherapy Cocktail?
    Wei-Yang Kong et al, 2021, Molecules CrossRef
  105. Periostin Exon-21 Antibody Neutralization of Triple-Negative Breast Cancer Cell-Derived Periostin Regulates Tumor-Associated Macrophage Polarization and Angiogenesis
    Tatsuya Fujikawa et al, 2021, Cancers CrossRef
  106. HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy
    Alexander E. Kabakov et al, 2021, Cells CrossRef
  107. A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer
    Muhammad Naeem et al, 2022, Molecules CrossRef
  108. Synergistic Effect of YK-4-279 and Paclitaxel on A549 Cell Line
    Sara Alkhatib et al, 2018 CrossRef
  109. USP11 deubiquitinates E-cadherin and maintains luminal fate of mammary tumor cells to suppress breast cancer
    Tao Qian et al, 2024, Journal of Biological Chemistry CrossRef
  110. The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors
    Mahsa Liaghat et al, 2024, Cell Commun Signal CrossRef
  111. Combination of Detoxified Pneumolysin Derivative ΔA146Ply and Berbamine as a Treatment Approach for Breast Cancer.
    Hong Zhang et al, 2020, Mol Ther Oncolytics CrossRef
  112. Molecular Mechanisms of Breast Cancer Drug Resistance and CRISPR/Cas9 Strategies to Overcome
    Bashdar Mahmud Hussen et al, 2024, Bio. Med. Tar. Jour. CrossRef